EVOKE PHARMA, INC. Retained Earnings
EVOKE PHARMA, INC. had Retained Earnings of -$132.82 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2025-11-13
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$132.82M.
- 2025-06-30: Retained Earnings (Accumulated Deficit) -$131.67M.
- 2025-03-31: Retained Earnings (Accumulated Deficit) -$130.10M.
- 2024-12-31: Retained Earnings (Accumulated Deficit) -$128.79M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2025-09-30 | -$132.82M 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$131.67M 10-Q · filed 2025-08-14 |
| 2025-03-31 | -$130.10M 10-Q · filed 2025-05-13 |
| 2024-12-31 | -$128.79M 10-Q · filed 2025-11-13 |
| 2024-09-30 | -$127.60M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$126.29M 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$125.02M 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$123.44M 10-K · filed 2025-03-13 |
| 2023-09-30 | -$121.45M 10-K/A · filed 2024-05-14 |
| 2023-06-30 | -$119.76M 10-K/A · filed 2024-05-14 |
| 2023-03-31 | -$117.89M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$115.65M 10-K/A · filed 2024-05-14 |
| 2022-09-30 | -$113.84M 10-Q · filed 2022-11-09 |
| 2022-06-30 | -$111.83M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$109.60M 10-Q · filed 2022-05-10 |
| 2021-12-31 | -$107.42M 10-K · filed 2023-03-21 |
| 2021-09-30 | -$105.75M 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$103.78M 10-Q · filed 2021-08-12 |
| 2021-03-31 | -$101.49M 10-Q · filed 2021-05-12 |
| 2020-12-31 | -$98.89M 10-K · filed 2022-03-08 |
| 2020-09-30 | -$96.62M 10-Q · filed 2020-11-10 |
| 2020-06-30 | -$94.49M 10-Q · filed 2020-08-06 |
| 2020-03-31 | -$87.52M 10-Q · filed 2020-05-12 |
| 2019-12-31 | -$85.73M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$84.31M 10-Q · filed 2019-11-07 |
| 2019-06-30 | -$82.68M 10-Q · filed 2019-08-08 |
| 2019-03-31 | -$80.57M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$78.60M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$76.84M 10-Q · filed 2018-11-13 |
| 2018-06-30 | -$75.32M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$73.02M 10-Q · filed 2018-05-14 |
| 2017-12-31 | -$71.04M 10-K · filed 2019-03-06 |
| 2017-09-30 | -$70.73M 10-Q · filed 2017-11-14 |
| 2017-06-30 | -$65.49M 10-Q · filed 2017-08-14 |
| 2017-03-31 | -$63.86M 10-Q · filed 2017-05-15 |
| 2016-12-31 | -$58.81M 10-K · filed 2018-03-07 |
| 2016-09-30 | -$57.28M 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$54.26M 10-Q · filed 2016-08-15 |
| 2016-03-31 | -$51.29M 10-Q · filed 2016-05-11 |
| 2015-12-31 | -$48.06M 10-K · filed 2017-03-15 |
| 2015-09-30 | -$45.44M 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$42.70M 10-Q · filed 2015-08-13 |
| 2015-03-31 | -$39.46M 10-Q · filed 2015-05-14 |
| 2014-12-31 | -$35.94M 10-K · filed 2016-03-10 |
| 2014-09-30 | -$33.02M 10-Q · filed 2014-11-13 |
| 2014-06-30 | -$29.19M 10-Q · filed 2014-08-13 |
| 2013-12-31 | -$22.69M 10-K · filed 2015-03-04 |